graft vs host disease
Showing 1 - 25 of 150
Alterations in Intestinal Microbiota, Metabolites, and Immune
Recruiting
- Graft Vs Host Disease
- Blood Sample
- +2 more
-
Suzhou, Jiangsu, ChinaThe First Affiliated Hospital of Soochow University
Nov 16, 2023
Tacrolimus Blood Concentration and Transplant-related Outcomes
Recruiting
- Graft Vs Host Disease
- +2 more
- TAC C/D ratio
-
Trieste, ItalyIRCCS Burlo Garofolo
Oct 6, 2023
Graft Vs Host Disease, Graft-versus-host-disease, GVHD Trial in Saint Louis (Ruxolitinib)
Not yet recruiting
- Graft Vs Host Disease
- +2 more
-
Saint Louis, MissouriWashington University School of Medicine
Aug 18, 2023
Graft Vs Host Disease, Graft-versus-host-disease, Acute Myeloid Leukemia Trial (CliniMACS® device)
Not yet recruiting
- Graft Vs Host Disease
- +5 more
- CliniMACS® device
- (no location specified)
Jul 20, 2023
Graft Vs Host Disease Trial in Puebla (Cyclophosphamide)
Enrolling by invitation
- Graft Vs Host Disease
-
Puebla, MexicoCentro de Hematología y Medicina Interna
Mar 22, 2023
Photopheresis in GvHD After Hematopoietic Transplantation:
Enrolling by invitation
- Graft Vs Host Disease
- Extracorporeal Photopheresis
- Extracorporeal Photopheresis
-
Roma, ItalyFondazione Policlinico Universitario Agostino Gemelli (FPG) - IR
Feb 7, 2023
Pediatric cGVHD Symptom Scale
Recruiting
- Graft vs Host Disease
-
Aurora, Colorado
- +11 more
Jan 27, 2023
Sickle Cell Disease, Thalassemia, Stem Cell Transplantation Trial run by the National Heart, Lung, and Blood Institute (NHLBI)
Recruiting
- Sickle Cell Disease
- +3 more
- Alemtuzumab
- +4 more
-
Bethesda, MarylandNational Institutes of Health Clinical Center
Jan 20, 2023
Stem Cell Transplant Complications, Graft Vs Host Disease, Myeloid Leukemia, Acute Trial in Boston (radiation, drug, biological,
Recruiting
- Stem Cell Transplant Complications
- +4 more
- Radiation
- +7 more
-
Boston, MassachusettsDana Farber Cancer Institute
Jan 19, 2023
MDS, Graft Vs Host Disease, Graft-versus-host-disease Trial in Miami (Busulfan, Melphalan, Fludarabine)
Not yet recruiting
- Myelodysplastic Syndromes
- +2 more
- Busulfan
- +3 more
-
Miami, FloridaMiami Cancer Institute
Jan 10, 2023
GVHD, Malignancy Trial in Canada, United States (Abatacept, )
Active, not recruiting
- Graft vs Host Disease
- Malignancy
- Abatacept
- placebo
-
Los Angeles, California
- +13 more
Jan 9, 2023
Evaluation of the Impact of Reduced Immunosuppression
Enrolling by invitation
- Graft Vs Host Disease
-
Dallas, TexasMethodist Dallas Medical Center
Dec 20, 2022
Precision Diagnostics in Inflammatory Bowel Disease, Cellular
Enrolling by invitation
- Graft Vs Host Disease
- +2 more
-
Boston, Massachusetts
- +1 more
Dec 7, 2022
Graft Vs Host Disease, Acute-graft-versus-host Disease, Chronic Graft-versus-host-disease Trial in Boston (Exercise, Attention
Recruiting
- Graft Vs Host Disease
- +2 more
- Exercise
- Attention control
-
Boston, Massachusetts
- +1 more
Nov 28, 2022
Graft Vs Host Disease Trial in New York (Cyclophosphamide, Abatacept, Tacrolimus)
Recruiting
- Graft Vs Host Disease
- Cyclophosphamide
- +2 more
-
New York, New YorkNYU Langone Health
Nov 10, 2022
The Influence of Extracorporeal Photopheresis on Skin Sclerosis
Completed
- Scleroderma, Systemic
- +4 more
-
Berlin, GermanyCharité-Universitätsmedizin Berlin
Nov 16, 2022
Scleroderma, Systemic, Morphea, Graft Vs Host Disease Trial in Murray (UVA-1 Phototherapy)
Enrolling by invitation
- Scleroderma, Systemic
- +2 more
- UVA-1 Phototherapy
-
Murray, UtahUniversity of Utah Dermatology
Nov 1, 2022
Graft Vs Host Disease, Graft-versus-host-disease Trial in San Francisco (CliniMacs®)
Recruiting
- Graft Vs Host Disease
- Graft-versus-host-disease
- CliniMacs®
-
San Francisco, CaliforniaUniversity of California, San Francisco
Aug 2, 2022
Graft Vs Host Disease, Peripheral Blood Stem Cell Transplantation, AML Trial in Germany (Cyclophosphamide, ATG)
Recruiting
- Graft Vs Host Disease
- +5 more
- Cyclophosphamide
- ATG
-
Augsburg, Germany
- +15 more
Aug 2, 2022
Graft Vs Host Disease, GVHD Trial in Tampa, Minneapolis (Pacritinib, Sirolimus, Tacrolimus)
Active, not recruiting
- Graft Vs Host Disease
- GVHD
- Pacritinib
- +2 more
-
Tampa, Florida
- +1 more
Jul 27, 2022
Graft Vs Host Disease, Colitis, Crohn Disease Trial in Oklahoma City (MSOT Device, Temperature Measurement)
Recruiting
- Graft Vs Host Disease
- +2 more
- MSOT Device
- Temperature Measurement
-
Oklahoma City, OklahomaOU Health Stephenson Cancer Center
Jun 28, 2022
Bronchiolitis Obliterans, Graft Vs Host Disease Trial in Palo Alto (Pirfenidone 267 MG [Esbriet])
Completed
- Bronchiolitis Obliterans
- Graft Vs Host Disease
- Pirfenidone 267 MG [Esbriet]
-
Palo Alto, CaliforniaStanford University School of Medicine
Jun 8, 2022